Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Urothelial Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableEnrolling By InvitationNCT07091565
What this trial is testing

Supporting Sexual Recovery in Women With Bladder Cancer

Who this might be right for
Bladder CancerCystectomyFemale Sexual Dysfunction
King's College London 60
Testing effectiveness (Phase 2)Ended earlyNCT01042795
What this trial is testing

Trial of Adjuvant Sutent for Patients With High Risk Urothelial Carcinoma After Neoadjuvant Chemotherapy and Cystectomy

Who this might be right for
Urothelial CarcinomaBladder Cancer
University of Michigan 7
Early research (Phase 1)Active Not RecruitingNCT05768347
What this trial is testing

Intravesical Adoptive Cell Therapy w/ TIL for BCG Exposed High Grade NMIBC

Who this might be right for
Urothelial CarcinomaNon-Invasive Bladder Urothelial Carcinoma
H. Lee Moffitt Cancer Center and Research Institute 9
Testing effectiveness (Phase 2)Study completedNCT00173862
What this trial is testing

Gemcitabine and Ifosfamide As a Second-Line Systemic Chemotherapy for Cisplatin -Failed Advanced TCC

Who this might be right for
Transitional Cell Carcinoma
National Taiwan University Hospital 18
Testing effectiveness (Phase 2)UnknownNCT03676946
What this trial is testing

A Clinical Study of PD-L1 Antibody ZKAB001（Drug Code） in Locally Advanced and Metastatic Urothelial Carcinoma

Who this might be right for
Urothelial Carcinoma
Lee's Pharmaceutical Limited 15
Testing effectiveness (Phase 2)Looking for participantsNCT05600127
What this trial is testing

Chemotherapy and Sequential Immunotherapy for Locally Advanced Urothelial Cancer

Who this might be right for
Urothelial Carcinoma
Erasmus Medical Center 64
Testing effectiveness (Phase 2)UnknownNCT04099589
What this trial is testing

Neoadjuvant Treatment of Upper Urinary and Muscular Invasive Bladder Urothelial Carcinoma

Who this might be right for
Upper Tract Urinary CarcinomaMuscle-invasive Bladder Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 64
Early research (Phase 1)Ended earlyNCT02608125
What this trial is testing

A Dose Escalation Study in Solid Tumors and a Dose Expansion Study of PRN1371 in Adult Patients With Metastatic Urothelial Carcinoma

Who this might be right for
Solid TumorsMetastatic Urothelial Carcinoma & Renal Pelvis & Ureter
Principia Biopharma, a Sanofi Company 45
Testing effectiveness (Phase 2)Ended earlyNCT00933374
What this trial is testing

Trial to Evaluate Paclitaxel Plus RAD001 in Urothelial Carcinoma

Who this might be right for
Bladder Cancer
Heinrich-Heine University, Duesseldorf 28
Not applicableStudy completedNCT03013920
What this trial is testing

CLE Characteristics of Upper Urinary Tract Urothelial Carcinoma

Who this might be right for
Urinary Tract CancerUrothelial CarcinomaUreter Cancer
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 150
Testing effectiveness (Phase 2)Study completedNCT01551030
What this trial is testing

Buparlisib in Metastatic Transitional Cell Carcinoma of the Urothelium

Who this might be right for
Metastatic Transitional Cell Carcinoma of the Urothelium
Memorial Sloan Kettering Cancer Center 19
Not applicableLooking for participantsNCT06167057
What this trial is testing

POST URS Chemotherapy Instillation

Who this might be right for
UTUC
Carmel Medical Center 264
Testing effectiveness (Phase 2)Looking for participantsNCT05269381
What this trial is testing

Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors

Who this might be right for
Anatomic Stage III Breast Cancer AJCC v8Anatomic Stage IIIA Breast Cancer AJCC v8Anatomic Stage IIIB Breast Cancer AJCC v8+98 more
Mayo Clinic 138
Early research (Phase 1)Active Not RecruitingNCT03212404
What this trial is testing

Phase 1 Study of CK-301 (Cosibelimab) as a Single Agent in Subjects With Advanced Cancers

Who this might be right for
Lung NeoplasmsCarcinoma, Non-Small-Cell LungCarcinoma, Small Cell+10 more
Checkpoint Therapeutics, Inc. 272
Testing effectiveness (Phase 2)Looking for participantsNCT04895709
What this trial is testing

BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors

Who this might be right for
Cervical CancerGastric/Gastroesophageal Junction AdenocarcinomaMicrosatellite Stable Colorectal Cancer+8 more
Bristol-Myers Squibb 1,109
Early research (Phase 1)Active Not RecruitingNCT06337084
What this trial is testing

Diagnostic Efficacy and Dosimetry of MNPR-101-DFO*-89Zr in Patients With Solid Tumors

Who this might be right for
Solid Tumor, AdultBladder CancerUrothelial Carcinoma+6 more
Monopar Therapeutics 12
Testing effectiveness (Phase 2)Ended earlyNCT03029832
What this trial is testing

MOXR0916 in Combination With Atezolizumab Versus Atezolizumab Alone in Participants With Untreated Locally Advanced or Metastatic Urothelial Carcinoma Who Are Ineligible for Cisplatin-Based Therapy

Who this might be right for
Urothelial Carcinoma
Genentech, Inc. 5
Testing effectiveness (Phase 2)Active Not RecruitingNCT04940299
What this trial is testing

Tocilizumab, Ipilimumab, and Nivolumab for the Treatment of Advanced Melanoma, Non-Small Cell Lung Cancer, or Urothelial Carcinoma

Who this might be right for
Clinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8Locally Advanced Bladder Carcinoma+39 more
M.D. Anderson Cancer Center 35
Testing effectiveness (Phase 2)Study completedNCT03674567
What this trial is testing

Dose Escalation and Expansion Study of FLX475 Monotherapy and in Combination With Pembrolizumab

Who this might be right for
Advanced Cancer
RAPT Therapeutics, Inc., a member of the GSK plc group of companies 323
Not applicableUnknownNCT06416319
What this trial is testing

Preoperative Physical Activity Improvement With the Use of Activity Trackers Before Radical Cystectomy (PreAct)

Who this might be right for
Bladder CancerBladder NeoplasmBladder Urothelial Carcinoma
Universitätsmedizin Mannheim 164
Next Page